NASP Press Release: NASP Statement on White House Drug Pricing Announcement

Please click here to read the press release NASP issued this morning in response to the September 30, 2025, launch of TrumpRx.gov, a new government website designed to partner with drug manufacturers to provide discounted pricing on select medications. NASP seeks additional clarity regarding which drugs will be included in this program and how both the Administration and manufacturers will ensure patients continue to receive the necessary clinical education, guidance, product support and care coordination provided by their specialty pharmacy.

If you have any questions or comments, please do not hesitate to reach out to us.